Clinical trial registration: This trial was not registered in the clinical trial database because it was an early phase trial and not a controlled study.
Phase I study of TAC-101, an oral synthetic retinoid, in Japanese patients with advanced hepatocellular carcinoma
Version of Record online: 18 JUN 2012
© 2012 Japanese Cancer Association
Volume 103, Issue 8, pages 1524–1530, August 2012
How to Cite
Okusaka, T., Ueno, H., Ikeda, M., Takezako, Y. and Morizane, C. (2012), Phase I study of TAC-101, an oral synthetic retinoid, in Japanese patients with advanced hepatocellular carcinoma. Cancer Science, 103: 1524–1530. doi: 10.1111/j.1349-7006.2012.02334.x
- Issue online: 26 JUL 2012
- Version of Record online: 18 JUN 2012
- Accepted manuscript online: 16 MAY 2012 02:02AM EST
- Manuscript Accepted: 8 MAY 2012
- Manuscript Revised: 6 MAY 2012
- Manuscript Received: 14 FEB 2012
- 9New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 2000; 92: 205–16., , et al.